A la carte: Drug Development Fundamentals | Dione Kobayashi, PhD
What is the process involved in taking a new drug from the laboratory to market? What are the barriers and logistical challenges along the way?…
Innovation MESH Network | Mass General Brigham
What is the process involved in taking a new drug from the laboratory to market? What are the barriers and logistical challenges along the way?…
Moderator: Gregg Meyer, MD, Chief Clinical Officer, PHS; Professor of Medicine, MGH and HMS Vasant Narasimhan, MD, CEO, Novartis
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.